Blog
FDA Releases Draft Guidance Concerning Regulatory Issues Surrounding Nanotechnology
A recent article on Medical News Today's website entitled “FDA Takes 'First Step' Toward Greater Regulatory Certainty Around Nanotechnology” reviews FDA's June 9th release of a draft guidance that provides regulated industries with greater certainty about the use of...
Exception from Informed Consent Requirements for Emergency Research
"In March 2011 FDA finalized guidance on exception of informed consent requirements for emergency research..." To see our COO's full guest blog entry, click here.
Pearl IRB invites you to a clinical research Webinar with IHA June 9, 2011
Please join us for an informative Webinar: 3pm EST on June 9, 2011 "Integrating and Sustaining Clinical Research" features Pearl IRB COO, Gretchen Miller Bowker Offering 1.5 hours of CE credit REGISTER NOW ABOUT THE WEBINAR Does your organization or practice have an...
Pearl speaking and exhibiting at MAGI’s Clinical Research Conference, Philadelphia, PA, May 22-25
This event is sure to be a great gathering for clinical research professionals. Gretchen Bowker, Pearl IRB COO is speaking on Monday, May 23rd at 10:30 am. Session title: Recent Developments in Human Subjects Protection Regulation and, where are we going? We will...
Welcome Rachel Ochs-Ross, MD., J.D. as a new co-chair of Pearl IRB Board
We are thrilled to have Rachel Ochs-Ross, M.D., J.D. join our Board as co-chair. She is an experienced Neurologist who has extensive experience guiding all phases of clinical drug development, from early compound assessment through Phase IV clinical studies and has...